Is fibrin formation and thrombin generation increased during and after an acute coronary syndrome?

Thrombosis Research

Volumn 128, Issue 5, 2011, Pages 483-489

  Skeppholm, Mika ^a   Kallner, Anders ^b   Malmqvist, Karin ^a   Blombäck, Margareta ^b   Wallén, Håkan ^a  

^a DANDERYD HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Coagulation; Fibrinolysis; Myocardial infarction; Thrombin generation potential

Indexed keywords

ACETYLSALICYLIC ACID; BIOLOGICAL MARKER; CLOPIDOGREL; DALTEPARIN; ENOXAPARIN; FIBRIN; LOW MOLECULAR WEIGHT HEPARIN; THROMBIN; TIROFIBAN; WARFARIN;

ACUTE CORONARY SYNDROME; ADULT; AGED; ANALYTIC METHOD; ARTICLE; BLOOD CLOTTING; CALIBRATED AUTOMATED THROMBOGRAM; CONTROLLED STUDY; CONVALESCENCE; FEMALE; FIBRIN FORMATION; FIBRINOLYSIS; HOSPITAL ADMISSION; HUMAN; IN VIVO STUDY; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; THROMBIN TIME;

ACUTE CORONARY SYNDROME; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BLOOD COAGULATION; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; FIBRIN; FIBRINOLYSIS; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; THROMBIN;

EID: 80055098005     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2011.03.011     Document Type: Article

References (34)

1. G. Davì, and C. Patrono Platelet activation and atherothrombosis N Engl J Med 357 2007 2482 2494
2. P.A. Merlini, K.A. Bauer, L. Oltrona, D. Ardissino, M. Cattaneo, and C. Belli Persistent activation of coagulation mechanism in unstable angina and myocardial infarction Circulation 90 1994 61 68 (Pubitemid 24203663)
3. A. Undas, K. Szuldrzynski, K.E. Brummel-Ziedins, W. Tracz, K. Zmudka, and K.G. Mann Systemic blood coagulation activation in acute coronary syndromes Blood 113 2009 2070 2078
4. J. Oldgren, A. Siegbahn, L. Grip, R. Linder, K. Thygesen, and L. Wallentin Myocardial damage, coagulation activity and the response to thrombin inhibition in unstable coronary artery disease Thromb Haemost 91 2004 381 387 (Pubitemid 38240186)
5. J.P. Bassand, C.W. Hamm, D. Ardissino, E. Boersma, A. Budaj, and F. Fernández-Avilés Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes: The Task Force for the Diagnosis and Treatment of Non-ST-Segment Elevation Acute Coronary Syndromes of the European Society of Cardiology Eur Heart J 28 2007 1598 1660 (Pubitemid 47227122)
6. J.W. Eikelboom, J.I. Weitz, A. Budaj, F. Zhao, I. Copland, and P. Maciejewski Clopidogrel does not suppress blood markers of coagulation activation in aspirin-treated patients with non-ST-elevation acute coronary syndromes Eur Heart J 23 2002 1771 1779 (Pubitemid 35334270)
7. J. Oldgren, R. Linder, L. Grip, A. Siegbahn, and L. Wallentin Coagulation Activity and Clinical Outcome in Unstable Coronary Artery Disease Arterioscler Thromb Vasc Biol 21 2001 1059 1064 (Pubitemid 34168669)
8. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, and K.K. Fox The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-elevation N Engl J Med 345 2001 494 502 (Pubitemid 32758501)
9. M. Hurlen, M. Abdelnoor, P. Smith, J. Erikssen, and H. Arnesen Warfarin, aspirin, or both after myocardial infarction N Engl J Med 347 2002 969 974
10. J.W. Eikelboom, S.R. Mehta, S.S. Anand, C. Xie, K.A. Fox, and S. Yusuf Adverse impact of bleeding on prognosis in patients with acute coronary syndromes Circulation 114 2006 774 782 (Pubitemid 44268228)
11. S.V. Manoukian, F. Feit, R. Mehran, M.D. Voeltz, R. Ebrahimi, and M. Hamon Impact of major bleeding on 30-day mortality and clinical outcomes in patients with acute coronary syndromes: an analysis from the ACUITY Trial J Am Coll Cardiol 49 2007 1362 1368 (Pubitemid 46476844)
12. S. He, K. Zhu, M. Skeppholm, J. Vedin, J. Svensson, and N. Egberg A global assay of haemostasis which uses recombinant tissue factor and tissue-type plasminogen activator to measure the rate of fibrin formation and fibrin degradation in plasma Thromb Haemost 98 2007 871 882 (Pubitemid 47555082)
13. http://www.ucr.uu.se/swedeheart 2011 Accessed February 24
14. E.M. Antman, M. Cohen, P.J. Bernink, C.H. McCabe, T. Horacek, and G. Papuchis The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making JAMA 284 2000 835 842 (Pubitemid 30643610)
15. K.W. Lee, A.D. Blann, and G.Y.H. Lip Plasma markers of endothelial damage/dysfunction, inflammation and thrombogenesis in relation to TIMI risk stratification in acute coronary syndromes Thromb Haemost 94 2005 1077 1083 (Pubitemid 41645952)
16. H.C. Hemker, and P. Giesen Al Dieri R, Regnault V, de Smedt E, Wagenvoord R, Lecompte T, and Béguin S. Calibrated automated thrombin generation measurement in clotting plasma Pathophysiol Haemost Thromb 33 2003 4 15
17. K. Kokame, Y. Nobe, Y. Kokubo, A. Okayama, and T. Miyata FRETS-VWF73, a first fluorogenic substrate for ADAMTS13 assay Br J Haematol 129 2005 93 100 (Pubitemid 40524057)
18. A. Undas, K.E. Brummel-Ziedins, and K.G. Mann Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions Blood 109 2007 2285 2292 (Pubitemid 46425865)
19. A. Bayes-Genis, J. Mateo, M. Santaló, A. Oliver, J. Guindo, and L. Badimon D-Dimer is an early diagnostic marker of coronary ischemia in patients with chest pain Am Heart J 140 2000 379 384
20. P.A. Merlini, A. Repetto, A. Lombardi, A. Vetrano, R. Fetiveau, and C. Cavallini Effect of Abciximab on prothrombin activation and thrombin generation in acute coronary syndromes without ST-segment elevation: Global Utilization of Strategies to Open Occluded Coronary Arteries Trial IV in acute coronary syndromes (GUSTO IV ACS) Italian Hematology Substudy Circulation 105 2002 928 932 (Pubitemid 34184569)
21. R.F.M. van der Putten, J.F.C. Glatz, and W.T. Hermens Plasma markers of activated hemostasis in the early diagnosis of acute coronary syndromes Clin Chim Acta 371 2006 37 54 (Pubitemid 44162911)
22. S. He, M. Blombäck, N. Bark, H. Johnsson, and N.H. Wallén The direct thrombin inhibitors (argatroban, bivalrudin and lepirudin) and the indirect Xa-inhibitor (danaparoid) increase fibrin network porosity and thus facilitate fibrinolysis Thromb Haemost 103 2010 1076 1084
23. M.H. Prins, and J. Hirsh A critical review of the relationship between impaired fibrinolysis and myocardial infarction Am Heart J 122 1991 545 551
24. M.E. Meltzer, C.J. Doggen, P.G. de Groot, F.R. Rosendaal, and T. Lisman Reduced plasma fibrinolytic capacity as a potential risk factor for a first myocardial infarction in young men Br J Haematol 145 2009 121 127
25. M. Skeppholm, N.H. Wallén, K. Malmqvist, A. Kallner, and J.P. Antovic Comparison of two immunochemical assays for measuring thrombin-activatable fibrinolysis inhibitor concentration with a functional assay in patients with acute coronary syndrome Thromb Res 121 2007 175 181 (Pubitemid 350138071)
26. A. Antovic, M. Blomback, K. Bremme, and S. He The assay of overall haemostasis potential used to monitor the low molecular mass (weight) heparin, dalteparin, treatment in pregnant women with previous thromboembolism Blood Coagul Fibrinolysis 13 2002 181 186 (Pubitemid 35001882)
27. J. Vedin, A. Antovic, A. Ericsson, and J. Vaage Hemostasis in off-pump compared to on-pump coronary artery bypass grafting: a prospective, randomized study Ann Thorac Surg 80 2005 586 593 (Pubitemid 41019485)
28. K.W. Lee, G.Y.H. Lip, M. Tayebjee, W. Foster, and A.D. Blann Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndroms Blood 105 2005 526 532 (Pubitemid 40070731)
29. P.M. Ridker, R.J. Glynn, and C.H. Hennekens C-Reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction Circulation 97 1998 2007 2011 (Pubitemid 28243661)
30. T.W. Meade, S. Mellows, M. Brozovic, G.J. Miller, R.R. Chakrabarti, and W.R. North Haemostatic function and ischemic heart disease: principal results of the Northwick Park Heart Study Lancet 2 1986 533 537 (Pubitemid 16054632)
31. A. Schumacher, I. Seljeflot, L. Sommervoll, B. Christensen, E. Otterstad Jan, and H. Arnesen Increased levels of endothelial haemostatic markers in patients with coronary heart disease Thromb Res 105 2002 25 31 (Pubitemid 34182832)
32. M. Matsukawa, K. Kaikita, K. Soejima, S. Fuchigami, Y. Nakamura, and T. Honda Serial Changes in von Willebrand Factor-Cleaving Protease (ADAMTS13) and Prognosis After Acute Myocardial Infarction Am J Cardiol 100 2007 758 763 (Pubitemid 47268262)
33. G. Yoo, M. Blomback, K. Schenk-Gustafsson, and S. He Decreased levels of von Willebrand factor-cleaving protease in coronary heart disease and trombotic thrombocytopenic purpura: study of a simplified method for assaying the enzyme activity based on ristocein-induced platelet aggregation Br J Haematol 121 2003 123 129 (Pubitemid 36461278)
34. C.K. Chion, C.J. Doggen, J.T. Crawley, D.A. Lane, and F.R. Rosendaal ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men Blood 109 2007 1998 2000 (Pubitemid 46348198)